These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


55 related items for PubMed ID: 8352550

  • 1. Inhibition of phospholipase D by agents that inhibit cell growth.
    Gratas C, Powis G.
    Anticancer Res; 1993; 13(4):1239-44. PubMed ID: 8352550
    [Abstract] [Full Text] [Related]

  • 2. Selective inhibition of phosphatidylinositol phospholipase C by cytotoxic ether lipid analogues.
    Powis G, Seewald MJ, Gratas C, Melder D, Riebow J, Modest EJ.
    Cancer Res; 1992 May 15; 52(10):2835-40. PubMed ID: 1316230
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of glycosylphosphatidylinositol (GPI) phospholipase D by suramin-like compounds.
    Brunner G, Zalkow L, Burgess E, Rifkin DB, Wilson EL, Gruszecka-Kowalik E, Powis G.
    Anticancer Res; 1996 May 15; 16(5A):2513-6. PubMed ID: 8917344
    [Abstract] [Full Text] [Related]

  • 4. U73122, an aminosteroid phospholipase C inhibitor, is a potent inhibitor of cardiac phospholipase D by a PIP2-dependent mechanism.
    Burgdorf C, Schäfer U, Richardt G, Kurz T.
    J Cardiovasc Pharmacol; 2010 Jun 15; 55(6):555-9. PubMed ID: 20179606
    [Abstract] [Full Text] [Related]

  • 5. Roles of brain phosphatidylinositol-specific phospholipase C and diacylglycerol lipase in centrally administered histamine-induced adrenomedullary outflow in rats.
    Shimizu T, Yamaguchi N, Okada S, Lu L, Sasaki T, Yokotani K.
    Eur J Pharmacol; 2007 Oct 01; 571(2-3):138-44. PubMed ID: 17628524
    [Abstract] [Full Text] [Related]

  • 6. Compound D609 inhibits phorbol ester-stimulated phospholipase D activity and phospholipase C-mediated phosphatidylethanolamine hydrolysis.
    Kiss Z, Tomono M.
    Biochim Biophys Acta; 1995 Oct 26; 1259(1):105-8. PubMed ID: 7492608
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of the signalling enzyme phosphatidylinositol-3-kinase by antitumor ether lipid analogues.
    Berggren MI, Gallegos A, Dressler LA, Modest EJ, Powis G.
    Cancer Res; 1993 Sep 15; 53(18):4297-302. PubMed ID: 8395981
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of growth factor binding, Ca2+ signaling and cell growth by polysulfonated azo dyes related to the antitumor agent suramin.
    Powis G, Seewald MJ, Melder D, Hoke M, Gratas C, Christensen TA, Chapman DE.
    Cancer Chemother Pharmacol; 1992 Sep 15; 31(3):223-8. PubMed ID: 1464160
    [Abstract] [Full Text] [Related]

  • 9. Novel ketoepoxides block phospholipase D activation and tumor cell invasion.
    Pai JK, Frank EA, Blood C, Chu M.
    Anticancer Drug Des; 1994 Aug 15; 9(4):363-72. PubMed ID: 7916902
    [Abstract] [Full Text] [Related]

  • 10. The ether lipid ET-18-OCH3 increases cytosolic Ca2+ concentrations in Madin Darby canine kidney cells.
    Jan CR, Wu SN, Tseng CJ.
    Br J Pharmacol; 1999 Jul 15; 127(6):1502-10. PubMed ID: 10455302
    [Abstract] [Full Text] [Related]

  • 11. The antisignaling agent SC-alpha alpha delta 9, 4-(benzyl-(2-[(2,5-diphenyloxazole-4-carbonyl)amino]ethyl)carbamoyl)- 2-decanoylaminobutyric acid, is a structurally unique phospholipid analogue with phospholipase C inhibitory activity.
    Vogt A, Pestell KE, Day BW, Lazo JS, Wipf P.
    Mol Cancer Ther; 2002 Sep 15; 1(11):885-92. PubMed ID: 12481409
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of neural phospholipase D activity by aminoglycoside antibiotics.
    Liscovitch M, Chalifa V, Danin M, Eli Y.
    Biochem J; 1991 Oct 01; 279 ( Pt 1)(Pt 1):319-21. PubMed ID: 1930152
    [Abstract] [Full Text] [Related]

  • 13. Eriochrome Black T, structurally related to suramin, inhibits angiogenesis and tumor growth in vivo.
    Morris AD, Léonce S, Guilbaud N, Tucker GC, Pérez V, Jan M, Cordi AA, Pierré A, Atassi G.
    Anticancer Drugs; 1997 Sep 01; 8(8):746-55. PubMed ID: 9396618
    [Abstract] [Full Text] [Related]

  • 14. Alkyl lysophospholipids inhibit phorbol ester-stimulated phospholipase D activity and DNA synthesis in fibroblasts.
    Kiss Z, Crilly KS.
    FEBS Lett; 1997 Jul 28; 412(2):313-7. PubMed ID: 9256242
    [Abstract] [Full Text] [Related]

  • 15. U-73122, an aminosteroid phospholipase C antagonist, noncompetitively inhibits thyrotropin-releasing hormone effects in GH3 rat pituitary cells.
    Smallridge RC, Kiang JG, Gist ID, Fein HG, Galloway RJ.
    Endocrinology; 1992 Oct 28; 131(4):1883-8. PubMed ID: 1396332
    [Abstract] [Full Text] [Related]

  • 16. Modulation of phospholipase D by hexadecylphosphorylcholine: a putative novel mechanism for its antitumoral activity.
    Lucas L, Hernández-Alcoceba R, Penalva V, Lacal JC.
    Oncogene; 2001 Mar 01; 20(9):1110-7. PubMed ID: 11314048
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of growth factor-dependent inositol phosphate Ca2+ signaling by antitumor ether lipid analogues.
    Seewald MJ, Olsen RA, Sehgal I, Melder DC, Modest EJ, Powis G.
    Cancer Res; 1990 Aug 01; 50(15):4458-63. PubMed ID: 2369723
    [Abstract] [Full Text] [Related]

  • 18. Phosphatidylcholine-specific phospholipase C and phospholipase D are respectively implicated in mitogen-activated protein kinase and nuclear factor kappaB activation in tumour-necrosis-factor-alpha-treated immature acute-myeloid-leukaemia cells.
    Plo I, Lautier D, Levade T, Sekouri H, Jaffrézou JP, Laurent G, Bettaïeb A.
    Biochem J; 2000 Oct 15; 351 Pt 2(Pt 2):459-67. PubMed ID: 11023832
    [Abstract] [Full Text] [Related]

  • 19. Stimulation of DNA synthesis in untransformed cells by the antiviral and antitumoral compound tricyclodecan-9-yl-xanthogenate (D609).
    Kiss Z, Crilly KS, Chung T.
    Biochem Pharmacol; 1998 Mar 15; 55(6):915-8. PubMed ID: 9586966
    [Abstract] [Full Text] [Related]

  • 20. Inhibition of phospholipase C-independent exocytotic responses in rat peritoneal mast cells by U73122.
    Gloyna W, Schmitz F, Seebeck J.
    Regul Pept; 2005 Feb 15; 125(1-3):179-84. PubMed ID: 15582730
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 3.